Farallon Capital Management LLC Savara Inc Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Savara Inc stock. As of the latest transaction made, Farallon Capital Management LLC holds 4,560,000 shares of SVRA stock, worth $14.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,560,000

Previous 4,560,000 -0.0%

Holding current value

$14.6 Million

Previous $18.4 Million 5.21%

% of portfolio

0.1%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.66 - $5.34 $7.93 Million - $11.6 Million	2,165,701 Added 90.45%	4,560,000 $18.4 Million
Q1 2024 May 15, 2024	SELL	$4.19 - $5.59 $16.2 Million - $21.6 Million	-3,861,107 Reduced 61.72%	2,394,299 $11.9 Million
Q4 2023 Feb 14, 2024	BUY	$3.18 - $4.9 $19.9 Million - $30.7 Million	6,255,406 New	6,255,406 $29.4 Million
Q3 2023 Nov 14, 2023	BUY	$2.97 - $3.88 $32.4 Million - $42.3 Million	10,908,086 New	10,908,086 $41.2 Million
Q1 2023 May 15, 2023	BUY	$1.6 - $2.82 $1.24 Million - $2.18 Million	773,125 Added 7.63%	10,908,086 $21.3 Million
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.64 $251,831 - $372,075	226,875 Added 2.29%	10,134,961 $15.7 Million
Q3 2022 Nov 14, 2022	BUY	$1.36 - $1.88 $449,905 - $621,928	330,813 Added 3.45%	9,908,086 $15.4 Million
Q2 2022 Aug 15, 2022	BUY	$1.1 - $1.58 $1.18 Million - $1.69 Million	1,071,870 Added 12.6%	9,577,273 $14.6 Million
Q1 2022 May 16, 2022	BUY	$1.05 - $1.36 $771,898 - $999,791	735,141 Added 9.46%	8,505,403 $11.1 Million
Q4 2021 Feb 14, 2022	BUY	$1.04 - $1.34 $1.31 Million - $1.69 Million	1,258,176 Added 19.32%	7,770,262 $9.64 Million
Q3 2021 Nov 15, 2021	BUY	$1.18 - $1.64 $1.25 Million - $1.74 Million	1,060,000 Added 19.44%	6,512,086 $8.99 Million
Q2 2021 Aug 13, 2021	BUY	$1.51 - $2.29 $2 Million - $3.04 Million	1,326,209 Added 32.14%	5,452,086 $9.27 Million
Q1 2021 May 17, 2021	SELL	$1.17 - $2.33 $381,664 - $760,066	-326,209 Reduced 7.33%	4,125,877 $8.58 Million
Q3 2020 Nov 16, 2020	SELL	$1.09 - $2.21 $20,577 - $41,720	-18,878 Reduced 0.42%	4,452,086 $4.85 Million
Q2 2020 Aug 14, 2020	SELL	$1.8 - $3.05 $637,419 - $1.08 Million	-354,122 Reduced 7.34%	4,470,964 $11.1 Million
Q4 2019 Feb 13, 2020	BUY	$0.71 - $4.91 $933,152 - $6.45 Million	1,314,299 Added 37.44%	4,825,086 $21.6 Million
Q3 2019 Nov 14, 2019	BUY	$2.16 - $3.2 $77,299 - $114,518	35,787 Added 1.03%	3,510,787 $9.3 Million
Q2 2019 Aug 14, 2019	BUY	$2.37 - $11.7 $2.49 Million - $12.3 Million	1,050,000 Added 43.3%	3,475,000 $8.24 Million
Q4 2018 Feb 14, 2019	BUY	$6.27 - $10.92 $43,833 - $76,341	6,991 Added 0.29%	2,425,000 $18.4 Million
Q3 2018 Nov 14, 2018	BUY	$10.49 - $12.87 $2.02 Million - $2.48 Million	193,009 Added 8.67%	2,418,009 $27 Million
Q3 2017 Nov 14, 2017	BUY	$5.1 - $9.55 $11.3 Million - $21.2 Million	2,225,000	2,225,000 $20.8 Million

Others Institutions Holding SVRA

# of Institutions

128

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $365M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Savara Inc Transaction History